Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V

The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability of a specific protein hydrolysate. It is derived from a whey protein concentrate and used in an infant and follow-on formula manufactured by FrieslandCampina Nederland B.V., which submitted a dossier to the European Commission to request an amendment of Regulation (EU) 2016/127 with respect to the protein sources that may be used in the manufacture of infant and/or follow-on formula. The protein hydrolysate under evaluation is sufficiently characterised with respect to the fraction of the hydroly... Mehr ...

Verfasser: Bohn T.
Castenmiller J.
de Henauw S.
Hirsch-Ernst K. -I.
Knutsen H. K.
Maciuk A.
Mangelsdorf I.
McArdle H. J.
Naska A.
Pentieva K.
Siani A.
Thies F.
Tsabouri S.
Vinceti M.
Bresson J. -L.
Castle L.
Fewtrell M.
Przyrembel H.
Dumas C.
Titz A.
Turck D.
Dokumenttyp: Artikel
Erscheinungsdatum: 2023
Schlagwörter: characterisation / clinical trial / follow-on formula / infant formula / nutritional safety / protein hydrolysate / suitability
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26766393
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://hdl.handle.net/11380/1312673